Real-world study of CIDP treatment outcomes
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how well current treatments work for people with CIDP (a nerve condition causing weakness). It tracks symptoms and daily function over time to help doctors understand which treatments may work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed CIDP diagnosis by a neurologist.
- You have been taking at least one CIDP treatment (like immunoglobulin, steroids, plasma exchange, or certain other drugs) for 3 months or more.
- You still have some difficulty with daily activities (scored 44 or below on a function test).
- You are 18 years or older.
- You are not currently in another clinical trial testing an experimental drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called DNTH103 for adults with CIDP, a condition that affects nerves and causes weakness. It aims to see if the drug can help people who are currently on treatment, have tried treatment before, or are new to treatment.
This study looks at how well efgartigimod works in everyday use for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It aims to understand the real-world benefits of this treatment.
This study looks at people with CIDP who are stable on IVIg treatment to see if we can predict when they might get worse if their treatment is adjusted. It aims to make treatment management easier and more personalized.
This study tests whether giving immune globulin under the skin (SCIG) can help people with newly diagnosed CIDP. It may help improve muscle strength and nerve symptoms while avoiding the need for earlier IVIG/SCIG treatment.
This trial tests whether a blood-filtering treatment called immunoadsorption can help people with CIDP. It is for adults who are already receiving or starting IVIg or MP therapy.
This study uses ultrasound to see how nerve inflammation changes over time in people with a chronic nerve disease called CIDP. It may help doctors choose the best treatment. The trial includes both newly diagnosed patients and those whose current treatment isn't working well.
Hear when a new Polyneuropathy, Inflammatory Demyelinating, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.